您当前的位置：
首页 >
文章列表页 >
Health insurance reimbursement management of off-label drug use in the United States and its implications for China
更新时间：2026-06-26

    • Health insurance reimbursement management of off-label drug use in the United States and its implications for China

    • ZHONGGUO YAOFANG   Vol. 37, Issue 12, Pages: 1535-1540(2026)

    • DOI：10.6039/j.issn.1001-0408.2026.12.03    

      CLC： R95

    • Received：02 February 2026，

      Revised：2026-03-13，

      Accepted：08 June 2026，

      Published：30 June 2026

    移动端阅览

  • CAO Keyao,LI Wei.Health insurance reimbursement management of off-label drug use in the United States and its implications for China[J].ZHONGGUO YAOFANG,2026,37(12):1535-1540. DOI： 10.6039/j.issn.1001-0408.2026.12.03.

  •  
  •  

0

Views

29

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

儿科超说明书用药的问题与对策
他莫昔芬超说明书用于促排卵的分析与管理
某精神专科医院2015年门诊药房超说明书用药处方分析
黄体酮注射液事件引起的安全用药思考
新疆某“三甲”医院儿科住院患儿超说明书用药情况调查与分析

Related Author

XING Rong
SONG Lele
LI Xiaojun
YAN Lili
WU Wenhui
JI Liu
YANG Rongmei
WANG Yantao

Related Institution

No data
0